INTRODUCTION
The ability of yeast to cope with and respond to freezing temperatures is a key point in the bread making process, and improvement of yeast freeze-tolerance has become a major focus of attention during last years (for a review see 1). This interest has increased by the enormous expansion of the frozen-dough market. Presently, the so-5 called frozen-dough technology makes up 10% of the sales of baked products in Europe and 25-30% worldwide, and it is expected a growing demand in the next future.
Freezing is often a lethal stress for yeast cells, as it causes denaturalization of macromolecules, ruptures of cell membranes and osmotic shrinkage with loss of water and turgor (2). During frozen storage, ice crystal growth further deteriorates the plasma 10 membrane and impairs activity in different cellular systems. Finally, during the thawing process, cells can suffer oxidative stress (3). As a consequence, the gassing power of yeast cells is reduced, increasing proofing time and lowering bread volume.
To overcome these problems, it is common for bakers to increase yeast dosages in these products by 4-10% above normal. However, this practice increases process cost 15 and affects negatively the taste and texture. Consequently, the development of yeast strains with better gassing power in frozen dough has a great economic interest.
Nowadays, no appropriate industrial baker's yeast with these desired properties is however available, and it is unlikely that classical breeding programs could provide significant improvements of these characteristics. Indeed, our limited understanding of 20 physiological and genetic determinants of freezing tolerance suggests that they are under control of multiple genes and complex regulatory mechanisms (4).
In this scenario, the ability to transform baker's yeast by recombinant DNA technology has opened the possibilities to manipulate just a single gene or pathway without altering other key or valuable genes for technological purposes (5, 6) . The 25 4 transfer of heterologous genes to S. cerevisiae has also meant that there is now the possibility of using baker's yeast as a cell factory. This has allowed in the past decade the development of industrial strains with unsuspected properties, giving to a new generation of baker's yeast (5) .
It has been reported that Antifreeze Proteins (AFPs), play a major role in the freeze 5 avoidance or freeze tolerance response of a wide range of organisms including bacteria, fungi, arthropods, plants and fish (for reviews see 7-9). The AFPs from polar fish species have been the most extensively characterized and are grouped into four classes on the basis of their amino acid composition. Type I is the smallest and simplest, which structure corresponds with an amphipathic alanine-rich α-helix chain (10) . Several 10 representatives of this class of protein have been described and all contain between three and five imperfect copies of an amino acid sequence motif composed mainly of alanine residues. These proteins fold with pairs of polar amino acid residues, known as ice-binding motifs (11) , spaced at regular intervals along the polar face of the helix.
These polar residues form hydrogen bonds with ice due to a lattice-matching 15 mechanism (12) , and the protein inhibits water deposition onto these surfaces of the ice crystal due to steric hindrance.
The activity of AFPs has attracted the attention of food biotechnologists interested in engineering freeze hardiness. Antifreeze proteins may inhibit recrystallization during freezing, frozen storage and thawing, thus preserving food texture and minimizing loss 20 of essential nutrients (13) . AFPs are naturally present in many foods consumed as part of the human diet and there are no evidences of adverse health effects (14) . In the case of fish AFPs, which intake is estimated as substantial in most northerly regions, is also reasonable to infer a lack of allergenicity (14) .
AFPs can be introduced into food products either by exogenous addition or by gene transfer. In this late case, the apparent simplicity of structure of the type I AFPs makes them particularly attractive, because it allows a relatively easy genetic manipulation.
However, their small size (Mr 3,000-5,000) and lack of globular tertiary structure have apparently rendered this class of protein susceptible to degradation when expressed in 5 heterologous host systems such as Escherichia coli, yeast, Drosophila and plants (10, 
15, 16).
Here we report how heterologous expression of a type I, alanine-rich AFP (17) , isolated from the polar fish known as grubby sculpin (Myoxocephalus aenaeus) provides a new alternative to face loss of viability of baker's yeast cells upon freezing 10 and frozen storage. GS-5 production through the secretory pathway using the prepro α-mating factor sequence of S. cerevisiae also enabled to increase gas production in a frozen liquid dough model system. Escherichia coli DH10B host strain was grown in Luria-Bertani (LB) medium (0.5% yeast extract, 1% peptone, 0.5% NaCl) supplemented with ampicillin (50mg/L). 20
MATERIALS AND METHODS 15

Yeast
Antibiotics and auxotrophic requirements were filter-sterilized and added to autoclaved medium.
DNA manipulations and plasmids. Plasmid YEpGS5 (URA3), which contains the GS-5 expression cassette was constructed as follows: fragments containing sequences of the yeast pheromone α-factor (MFα1) prepro region (-13 to +273), PGK1 terminator,7 T PGK1 (+1064 to +1544) and ACT1 promoter, P ACT1 (-497 to +11) were obtained by standard PCR using specific synthetic oligonucleotides (Table 1 ). The amplified P ACT1 fragment was digested with BamHI and EcoRI and cloned into the pBlueScriptII SK vector (Stratagen, La Jolla, CA), obtaining the plasmid pBS-P ACT . Then, the amplified prepro α-factor sequence was cloned into the pGEM-T Easy Vector (Promega, 5
Madison, WI), treated with EcoRI and HindIII, and inserted into the pBS-P ACT plasmid, resulting in plasmid pBS-P ACT α.
The GS-5 coding DNA fragment was synthesized by PCR using first two specific 60-bp oligonucleotides, GSL-1 and GSL-2, designed to overlap in 10 bp (Table 1) . After a first cycle of primer extension, amplification of GS-5 DNA was continued using 10 primers GSC-1 and GSC-2 (Table 1 ). The amplified fragment was subcloned into the pGEM-T Easy Vector (Promega), obtaining the plasmid pGEM-GS5. This was digested with HindIII and ClaI, and the released GS-5 fragment was inserted into the pBS-P ACT α plasmid, obtaining the plasmid pBS-P ACT αGS5. This was treated with ClaI and SalI, and used to accommodate the T PGK1 fragment previously digested with the same 15 set of enzymes, obtaining the plasmid pBS-P ACT αGS5T PGK . Finally, the GS-5 expression cassette was accommodated into the vector YEplac195 (21) by digestion with BamHI and SalI.
Yeast cells were transformed according to (22) and transformants were selected by auxotrophic complementation in SD plates. E. coli was transformed by electroporation 20 following the manufacturer's instructions (Eppendorf).
Gas production measurements. Yeast biomass was inoculated in LD, incubated at which contain the GS-5 sequence adjusted to the S. cerevisiae preferred codon usage (24) . In addition, the oligonucleotides were designed to remove the ATG of the wildtype GS-5 encoding sequence by the change of A to T and to add a stop codon. This change allows the in-frame expression of the GS-5 sequence and introduces a single 15 replacement at residue 1 from methionine to leucine. Nucleotides at the 5'-ends for the restriction sites HindIII and ClaI, were also included to allow its later manipulation.
After an extension phase of the assembled oligonucleotides, the complete fragment was amplified by PCR, ligated into an appropriate vector and the nucleotide sequence of the insert was determined to confirm its identity. A schematic representation of the strategy 20 of synthesis and cloning of the AFP is shown in Figure 1 .
To obtain the expression of the recombinant peptide, the GS-5 sequence was placed under the control of the S. cerevisiae ACT1 promoter, a strong constitutive promoter widely used for the production of heterologous proteins in baker's yeast (25, 26) . The expression cassette also comprised the terminator of the PGK1 gene and the signal 25 9 sequence and leader region of the yeast prepro α-mating factor (MFα1 gene), which was fused in-frame upstream of the GS-5 sequence (Figure 1 ). The prepro α-factor sequence is an efficient secretion vehicle for heterologous proteins, as it is processed through the secretory pathway and digested by specific proteases, releasing thus the biologically active protein (27). The final construct (Figure 1 ) generated in the shuttle 5 vector YEplac195 (21) was used to transform the laboratory W303-1A and the industrial HS13 strain. Transformants were selected by auxotrophic complementation and the functionality of the AFP-producing strains analyzed.
Production of the recombinant AFP GS-5 increases freeze tolerance in yeast.
Transformants of each strain under assay were selected for testing the ability of 10 recombinant GS-5 to enhance freeze tolerance in yeast. Cells were inoculated in a flourfree liquid dough model system (LD), shifted to -20ºC, and at different times, samples were thawed and the number of viable cells was determined by their colony-forming ability. We choose the LD system because it mimics the main nutrient composition of bread dough and permit the easy collection of isolated yeast cells and testing of 15 functional properties (19) . In all cases, yeast cells transformed with the empty plasmid YEplac195 were used as control. As it can be seen (Figure 2 ), the two strains analyzed differed in their susceptibility to freezing and frozen storage. Cells of the industrial HS13 strain showed a rapid and strong loss of viability, even after only 1 day at -20ºC.
On the contrary, at least 50% of the laboratory wild-type strain cells survived 13 days at 20 this temperature. The degree of freeze tolerance acquired by overexpression of GS-5 was also dependent on the strain tested. Although production of the AFP in the laboratory strain resulted in a certain protection against freeze damage, this effect was significantly larger in transformants of the HS13 strain ( Figure 2) . As an example, the number of viable cells in YEpGS5 transformants of the HS13 strain was 32-fold higher 25 than in the wild-type after 13 days at -20ºC. Thus the expression of the AFP GS-5 increases freeze tolerance in yeast, but the magnitude of this response appears to correlate with the basal sensitivity of the yeast strain assayed.
We also tested if the increase of freeze tolerance observed by expression of the AFP GS-5 in the industrial strain, determines an enhanced CO 2 production in frozen dough. 5
Again, cells were inoculated in the LD model system and their gassing power tested after freezing at -20ºC and frozen storage (Figure 3) . CO 2 production by HS13 cells was reduced markedly after freezing for 3 h and thawing (see point marked as 0' in Figure   3 ). This loss was similar in either of the transformants tested, around 30% with respect to unfrozen samples, suggesting that the recombinant AFP does not impart 10 osmoprotection. Effects on leavening activity of yeast cells upon freezing and thawing has been mainly attributed to desiccation and electrolyte release giving to hyperosmotic stress (28) . On the contrary, expression of the antifreeze peptide GS-5 enhanced gas production capacity during frozen storage. Indeed, after 40 days at -20ºC the production of CO 2 in samples inoculated with cells of the YEpGS5 transformant was 30% higher 15 than that found in control (YEplac195) samples (Figure 3) . Nevertheless, these differences were less pronounced than those seen in the viable cells assay (Figure 2 ). Thus, it seems that a number of cells unable to form colonies on YPD plates are still metabolically active, at least in terms of CO 2 production.
The production of the AFP GS-5 does not confer osmotic stress resistance in 20
yeast. Studies by Meijer et al. (29) reported that expression of fish AFPs in E. coli has an osmoprotective function. This property has been attributed to an interaction between antifreeze peptides and membrane lipids, which would reduce membrane permeability and inhibit leakage from cells (30) . However, the CO 2 production data reported in this study (Figure 3 The error associated with the points was < 5% of the value of the point. dw, dry weight. 
